{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:00:05Z","timestamp":1791968405556,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000090","name":"US Office of Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xcrm.2025.102359","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:01:58Z","timestamp":1758081718000},"page":"102359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records"],"prefix":"10.1016","volume":"6","author":[{"given":"Chunlei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora S.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhan V.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael R.","family":"Fillmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102359_bib1","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102359_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.102359_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104888","article-title":"A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data","volume":"98","author":"Jia","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2025.102359_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/NAQ.0000000000000118","article-title":"The Veterans Affairs\u2019s Corporate Data Warehouse: Uses and Implications for Nursing Research and Practice","volume":"39","author":"Price","year":"2015","journal-title":"Nurs. Adm. Q."},{"key":"10.1016\/j.xcrm.2025.102359_bib5","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.102359_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02942-5","article-title":"Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer","volume":"9","author":"Klein","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102359_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/1055-9965.EPI-19-1389","article-title":"Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population","volume":"29","author":"Kim","year":"2020","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.xcrm.2025.102359_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/carcin\/bgs151","article-title":"Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer","volume":"33","author":"Li","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.xcrm.2025.102359_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ng.522","article-title":"A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33","volume":"42","author":"Petersen","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102359_bib10","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ng.429","article-title":"Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer","volume":"41","author":"Amundadottir","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102359_bib11","unstructured":"Pancreatic Cancer Risk Factors. (2024). https:\/\/www.cancer.org\/cancer\/types\/pancreatic-cancer\/causes-risks-prevention\/risk-factors.html."},{"key":"10.1016\/j.xcrm.2025.102359_bib12","article-title":"Early Detection: Catching Cancer When It\u2019s Curable","author":"Ratner","year":"2024","journal-title":"OR Books"},{"key":"10.1016\/j.xcrm.2025.102359_bib13","article-title":"BEHRT: Transformer for Electronic Health Records","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102359_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-021-00455-y","article-title":"Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction","volume":"4","author":"Rasmy","year":"2021","journal-title":"NPJ Digit. Med."},{"key":"10.1016\/j.xcrm.2025.102359_bib15","article-title":"ClinicalBERT: Modeling Clinical Notes and Predicting Hospital Readmission.","author":"Huang","year":"2020","journal-title":"Proceedings of the ACM Conference on Health, Inference, and Learning (CHIL'20 Workshop Track). ACM"},{"key":"10.1016\/j.xcrm.2025.102359_bib16","series-title":"Proceedings of the 28th International Joint Conference on Artificial Intelligence, IJCAI 2019 5953\u20135959 (International Joint Conferences on Artificial Intelligence","article-title":"Pre-training of graph augmented transformers for medication recommendation","author":"Shang","year":"2019"},{"key":"10.1016\/j.xcrm.2025.102359_bib17","series-title":"ICLR 2023 Workshop on Trustworthy Machine Learning for Healthcare","article-title":"Extended Transformer for Electronic Health Records","author":"Rupp","year":"2023"},{"key":"10.1016\/j.xcrm.2025.102359_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejca.2020.10.019","article-title":"Development and validation of a pancreatic cancer risk model for the general population using electronic health records: An observational study","volume":"143","author":"Appelbaum","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102359_bib19","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2025.102359_bib20","article-title":"Upcoding Medicare: is healthcare fraud and abuse increasing?","volume":"18","author":"Coustasse","year":"2021","journal-title":"Perspect. Health Inf. Manag."},{"key":"10.1016\/j.xcrm.2025.102359_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13561-023-00465-4","article-title":"Upcoding in medicare: where does it matter most?","volume":"14","author":"Joiner","year":"2024","journal-title":"Health Econ. Rev."},{"key":"10.1016\/j.xcrm.2025.102359_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1158\/1055-9965.EPI-21-0786","article-title":"Use of Proton Pump Inhibitors and Risk of Pancreatic Cancer: A Nationwide Case\u2013Control Study Based on the French National Health Data System (SNDS)","volume":"31","author":"Lassalle","year":"2022","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.xcrm.2025.102359_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082220","article-title":"Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies","volume":"12","author":"Hong","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2025.102359_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canep.2016.12.006","article-title":"Proton pump inhibitors on pancreatic cancer risk and survival","volume":"46","author":"Kearns","year":"2017","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.xcrm.2025.102359_bib25","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2019-0053","article-title":"Anticancer activity of metformin: a systematic review of the literature","volume":"5","author":"Aljofan","year":"2019","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.xcrm.2025.102359_bib26","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/jdi.13301","article-title":"Effects of metformin on blood glucose levels and bodyweight mediated through intestinal effects","volume":"11","author":"Harada","year":"2020","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.xcrm.2025.102359_bib27","doi-asserted-by":"crossref","unstructured":"Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. (2002) doi:https:\/\/doi.org\/10.1056\/NEJMoa012512.","DOI":"10.1056\/NEJMoa012512"},{"key":"10.1016\/j.xcrm.2025.102359_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cmet.2020.08.013","article-title":"Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes","volume":"32","author":"Cheng","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2025.102359_bib29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","article-title":"Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation","volume":"54","author":"Xian","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102359_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00067","article-title":"Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations","volume":"2","author":"Topaloglu","year":"2018","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.xcrm.2025.102359_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41591-023-02332-5","article-title":"A deep learning algorithm to predict risk of pancreatic cancer from disease trajectories","volume":"29","author":"Placido","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102359_bib32","first-page":"3319","article-title":"Axiomatic Attribution for Deep Networks. Proceedings of the 34th International Conference on Machine Learning (ICML)","volume":"70","author":"Sundararajan","year":"2017","journal-title":"PMLR"},{"key":"10.1016\/j.xcrm.2025.102359_bib33","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102359_bib34","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.3748\/wjg.v20.i9.2279","article-title":"Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer","volume":"20","author":"Swierczynski","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2025.102359_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0016-5085(95)90291-0","article-title":"Pancreatitis is a risk factor for pancreatic cancer","volume":"109","author":"Bansal","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2025.102359_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102359_bib37","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.3748\/wjg.v27.i30.4939","article-title":"Diabetes and pancreatic cancer: Exploring the two-way traffic","volume":"27","author":"Roy","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2025.102359_bib38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1186\/1471-2407-14-814","article-title":"Effects of insulin on human pancreatic cancer progression modeled in vitro","volume":"14","author":"Chan","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.102359_bib39","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41467-023-38088-2","article-title":"Pancreatic cancer is associated with medication changes prior to clinical diagnosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102359_bib40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1517\/14740331003662620","article-title":"Statin Use and Cancer Risk: A Comprehensive Review","volume":"9","author":"Boudreau","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.xcrm.2025.102359_bib41","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102359_bib42","series-title":"A Survey on Bias and Fairness in Machine Learning","author":"Usc-Isi","year":"2021"},{"key":"10.1016\/j.xcrm.2025.102359_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102359_bib44","article-title":"Correcting Sample Selection Bias by Unlabeled Data","volume":"19","author":"Huang","year":"2006","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.xcrm.2025.102359_bib45","unstructured":"FDA Approved list of inactive ingredients. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/inactive-ingredients-database-download."},{"key":"10.1016\/j.xcrm.2025.102359_bib46","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s10620-024-08324-w","article-title":"Development and Validation of Case-Finding Algorithms to Identify Pancreatic Cancer in the Veterans Health Administration","volume":"69","author":"Mezzacappa","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.xcrm.2025.102359_bib47","series-title":"Advances in Neural Information Processing Systems (NeurIPS","first-page":"5998","article-title":"Attention Is All You Need","volume":"30","author":"Vaswani","year":"2017"},{"key":"10.1016\/j.xcrm.2025.102359_bib48","series-title":"Environmental Epidemiology: Principles and Methods","author":"Merrill","year":"2008"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912500432X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912500432X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:10:13Z","timestamp":1782490213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912500432X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S266637912500432X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102359","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.03.25323240","asserted-by":"object"}]},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102359"}}